Literature DB >> 23583221

MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.

Guo Li1, Yong Liu1, Zhongwu Su1, Shuling Ren1, Gangcai Zhu1, Yongquan Tian1, Yuanzheng Qiu2.   

Abstract

PURPOSE: Radioresistance severely restricts the clinical treatment of nasopharyngeal carcinoma (NPC). Accumulating evidence demonstrates that aberrant expression of microRNAs (miRNAs) contributes to cancer progression and sensitivity to radiation. Therefore, we aimed to identify miRNAs associated with radioresistance in NPC.
METHODS: Aberrant miRNA-324-3p expression in NPC CNE-2 cells with radioresistance (CNE-2-Rs), compared to its parental cells, was screened by high-throughput sequencing technology and determined by quantitative reverse transcription-polymerase chain reaction analysis (qRT-PCR) analysis. Bioinformatic analysis was used to predict the downstream target genes of miRNA-324-3p. Then, functional and mechanical analyses of miRNA-324-3p in NPC radioresistance were performed by overexpression and down-regulation of miRNA-324-3p in CNE-2-Rs cells and its parental cells. Finally, the clinical significance of miRNA-324-3p and WNT2B was investigated in NPC tissues.
RESULTS: Our data reveal that the expression of miRNA-324-3p is significantly decreased in CNE-2-Rs cells compared to its parental cells, and WNT2B is predicted to be the downstream target of miRNA-324-3p. Both overexpression and down-regulation of miRNA-324-3p following irradiation result in radiosensitivity alterations and protein changes of WNT2B signalling pathway in CNE-2-Rs cells and its parental cells. Importantly, down-regulation of miRNA-324-3p and up-regulation of WNT2B are significantly correlated with advanced clinical stages of NPC and this inverse expression pattern is also observed in NPC tissues before and after irradiation.
CONCLUSIONS: The present study reveals that miRNA-324-3p contributes to the radioresistance of NPC by regulating the WNT2B signalling pathway. Both miRNA-324-3p and WNT2B are potential biomarkers for radioresistance in NPC, which may serve as valuable targets for reversing radioresistance in the management of NPC. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583221     DOI: 10.1016/j.ejca.2013.03.001

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  54 in total

1.  MiR-98 inhibits malignant progression via targeting MTDH in squamous cell carcinoma of the head and neck.

Authors:  Haolei Tan; Gangcai Zhu; Li She; Ming Wei; Yunyun Wang; Leiming Pi; Changhan Chen; Diekuo Zhang; Pingqing Tan; Jie Chen; Donghai Huang; Yongquan Tian; Yong Liu; Xin Zhang
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Downregulation of microRNA-21 enhances radiosensitivity in nasopharyngeal carcinoma.

Authors:  Honghai Zhu; Xiaoyuan Zhu; Genyang Cheng; Minghui Zhou; Weihua Lou
Journal:  Exp Ther Med       Date:  2015-04-02       Impact factor: 2.447

3.  Role of miR-100 in the radioresistance of colorectal cancer cells.

Authors:  Xiao-Dong Yang; Xiao-Hui Xu; Shu-Yu Zhang; Yong Wu; Chun-Gen Xing; Gan Ru; Hong-Tao Xu; Jian-Ping Cao
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

4.  MicroRNA-381 increases radiosensitivity in esophageal squamous cell carcinoma.

Authors:  Suna Zhou; Wenguang Ye; Juan Ren; Qiuju Shao; Yuhong Qi; Jun Liang; Mingxin Zhang
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

5.  Antitumor effects of WNT2B silencing in GLUT1 overexpressing cisplatin resistant head and neck squamous cell carcinoma.

Authors:  Sheng-Jiao Li; Xiao-Ning Yang; Han-Yu Qian
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

6.  Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.

Authors:  Ana B Pavel; Joshua D Campbell; Gang Liu; David Elashoff; Steven Dubinett; Kate Smith; Duncan Whitney; Marc E Lenburg; Avrum Spira
Journal:  Cancer Prev Res (Phila)       Date:  2017-09-06

7.  MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals.

Authors:  Qing Lv; Jin-Xia Hu; You-Jie Li; Ning Xie; Dan Dan Song; Wei Zhao; Yun-Fei Yan; Bao-Sheng Li; Ping-Yu Wang; Shu-Yang Xie
Journal:  Cancer Biol Ther       Date:  2017-01-20       Impact factor: 4.742

8.  Deregulation of AKT-mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma.

Authors:  Changxian Shen; Duan-Liang Shyu; Min Xu; Linlin Yang; Amy Webb; Wenrui Duan; Terence M Williams
Journal:  Mol Cancer Res       Date:  2022-03-01       Impact factor: 6.333

Review 9.  The emerging roles of exosomal miRNAs in nasopharyngeal carcinoma.

Authors:  Chaoliang Liao; Huiwen Liu; Xiangjian Luo
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

10.  MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14).

Authors:  Tian Zhang; Quanquan Sun; Tongxin Liu; Jiarong Chen; Shasha Du; Chen Ren; Guixiang Liao; Yawei Yuan
Journal:  Tumour Biol       Date:  2014-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.